HCWB Research and Charts

HCWB - HCW Biologics Inc (Healthcare: Biotechnology)

Projected Earnings Date: 0000-02-29 (Delayed quote data 2025-07-11)

Last 4.35	Change ⇑ +0.03 (+0.69%)	Volume 37,264
	Open 4.31	High 4.42	Low 4.29

8EMA (Daily) 4.26	40EMA (Daily) 5.18	50EMA (Daily) 5.17	STO (Daily) 33.436	MACD Hist (Daily) 0.076
8EMA (Weekly) 5.084	40EMA (Weekly) 3.40	50EMA (Weekly) 3.04	STO (Weekly) 24.920	MACD Hist (Weekly) -0.753


Company Profile
HCW Biologics Inc is a preclinical stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link between chronic, low-grade inflammation and age-related diseases. It is developing HCW9218 as an injectable immunotherapeutic for patients with solid tumors.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.